Cognitive Deficits Active Not Recruiting Phase Trials for Golimumab (DB06674)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

Indication	Status	Phase
DBCOND0044823 (Cognitive Deficits)	Active Not Recruiting	Not Available

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04378621	Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients	Treatment	Adalimumab (DB00051) Baricitinib (DB11817) Certolizumab pegol (DB08904) Etanercept (DB00005) Golimumab (DB06674) Infliximab (DB00065) Tofacitinib (DB08895)